UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave Aurora, CO 80045Phone: 720-848-0000
Jennifer Diamond, MD
Medical Oncology
Board Certified
Clinical Interest for Patients
I treat patients with breast cancer at all stages with both conventional and clinical trial treatment options.
Credentials
Doctor of Medicine
Specialty
Internal Medicine, Medical Oncology
Scheduling Phone Number
720-848-1030
Gender
Female
Languages
English
Hospital Affiliation
University of Colorado Hospital
UCHealth Diane O'Connor Thompson Breast Center - Anschutz
Phone: 720-848-1030 720-848-1030
University of Colorado Cancer Center
CU Anschutz Medical Campus
1665 Aurora Ct Aurora, CO 80045Phone: 720-848-0300
Provider Information
Specialties
- Internal Medicine (2007)
- Medical Oncology (2010)
Conditions
-
Cancers
Breast Cancer
Department
Professor, Medicine-Medical Oncology
Professional Memberships
American Association for Cancer Research, Associate Member American Society of Clinical Oncology (ASCO), Member
Research and Grants
Research Interests for Patients
My research interests are in the new development of targeted agents for the treatment of breast cancer with innovative biomarker selection strategies.
Education and Training
Medical Schools
MD, University of Arizona College of Medicine (2004)
Undergraduate Schools
BA, University of Arizona (AZ) (2000)
Internships
University of Colorado (University Hospital) Program (2005)
Residency Program
University of Colorado (University Hospital) Program (2007)
Fellowships
University of Colorado (University Hospital) Program (2010)
Information for referring providers
Referral Contact Phone
720-848-1030
Referring Patients Link
Clinical Interests for Referring Providers
My practice is focused on the clinical care of patients with breast cancer including conventional and clinical trial treatments. I have a subspecialty interest in phase I clinical trials for patients with breast cancers and triple-negative breast cancer.
Research Interest for Referring Providers
My research interests are in the new development of targeted agents for the treatment of breast cancer with innovative biomarker selection strategies.